Carvedilol ER 40 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FN3XZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,151
Award facts
- Contract value 100% obligated
- $7,150.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,150.73 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that supports comprehensive pharmaceutical and medical supply needs for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical supplies. This particular delivery order for Carvedilol, a cardiovascular medication, represents routine pharmaceutical provisioning under the company's established relationship with DLA's Medical Supply Chain to support defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FN3XZ?
SPE2DB25FN3XZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FN3XZ worth?
The government has obligated $7,151 on SPE2DB25FN3XZ.
Is contract SPE2DB25FN3XZ an order under another contract?
Yes. SPE2DB25FN3XZ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3XZ competed?
The extent of competition for SPE2DB25FN3XZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award